Skip to main content

Novanta Inc. (NOVT) Stock Forecast

Data as of May 3, 2026

Technology · Current price $128.93 (-0.46%)

Consensus Target
$150.00
Upside
+16.3%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $150.00High $150.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Feb 25, 2026Robert MasonRobert W. Baird$150.00+16.3%
Aug 7, 2024Robert MasonRobert W. Baird$175.00+35.7%

NOVT vs Sector & Market

MetricNOVTTechnology AvgLarge Cap Avg
Analyst Rating2.002.342.41
Analyst Count11318
Target Upside+16.3%+4072.7%+14.9%
P/E Ratio88.3127.8231.19

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$256M$257M$258M2
2026-09-30$261M$262M$263M1
2026-12-31$271M$272M$274M1
2027-12-31$1.11B$1.11B$1.12B2

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$0.84$0.86$0.872
2026-09-30$0.92$0.92$0.931
2026-12-31$0.99$1.00$1.011
2027-12-31$4.02$4.05$4.082

Frequently Asked Questions

What is the analyst consensus for NOVT?

The consensus among 1 analysts covering Novanta Inc. (NOVT) is Buy with an average price target of $150.00.

What is the highest price target for NOVT?

The highest price target for NOVT is $175.00, set by Robert Mason at Robert W. Baird on 2024-08-07.

What is the lowest price target for NOVT?

The lowest price target for NOVT is $150.00, set by Robert Mason at Robert W. Baird on 2026-02-25.

How many analysts cover NOVT?

1 analysts have issued ratings for Novanta Inc. in the past 12 months.

Is NOVT a buy or sell right now?

Based on 1 analyst ratings, NOVT has a consensus rating of Buy (2.00/5) with a +16.3% upside to the consensus target of $150.00.

What are the earnings estimates for NOVT?

Analysts estimate NOVT will report EPS of $0.86 for the period ending 2026-06-30, with revenue estimated at $257M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.